Startups
PharmAI’s mission is to make early-stage drug discovery far more efficient by increasing success rates while reducing costs. The company develops groundbreaking AI-powered software for the analysis of 3D protein structures. This technology helps drastically shorten the timeline for discovery of new therapeutic molecules. PharmAI was founded in 2019 as a spin-off from the Dresden University of Technology.
Overview
Location
Germany, Saxony, Dresden
Employees
11-50
Founded date
2019
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 24, 2021 | NanoTemper and PharmAI: together faster to new drugs | NanoTemper Technologies and PharmAI collaborate to find suitable drug candidates by screening huge amounts of data. Finding new drugs faster and easier: That's the goal of the collaboration between Dresden-based start-up PharmAI and Munich... |
Reviews 0
FAQ about PharmAI GmbH
When was PharmAI GmbH founded?
PharmAI GmbH was founded in 2019.
What has the press written about PharmAI GmbH?
Parsers VC has collected 2 articles mentioning PharmAI GmbH, among them “NanoTemper and PharmAI: together faster to new drugs” (Mar 24, 2021).
Is PharmAI GmbH still active?
Yes, PharmAI GmbH is active; its latest activity on Parsers VC dates from Jan 24, 2024.